Efficacy of Symbravo&#174; (MoSEIC(TM) meloxicam and rizatriptan) by Baseline Migraine-associated Disability: Post-hoc Analysis of the INTERCEPT Trial

Symbravo (meloxicam/rizatriptan) - Axsome Therap

Todd Grinnell1; Stewart Tepper2; Angad Chhabra1; Graham Eglit1; Herriot Tabuteau1

Mar 6, 2026